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Pacemaker lead perforation is a complication associated with
screwing in the pacemaker lead.1 Nonsurgical management
of this complication is limited. Pericardial drainage is
performed for the resultant cardiac tamponade, but it is
difﬁcult to stop bleeding from the perforation site without
surgery. Here, we describe a case in which ﬁbrin glue
injected via a 6 F pericardial tube into the pericardium
successfully patched a lead perforation.
Case report
An 85-year-old woman experienced some episodes of syn-
cope. Electrocardiography showed a sinus pause of 45
seconds after paroxysmal atrial ﬁbrillation stopped. Thus,
the patient was diagnosed with sick sinus syndrome. Treat-
ment with apixaban 2.5 mg twice daily was initiated for the
paroxysmal atrial ﬁbrillation. Pacemaker (PM) implantation
was performed and apixaban anticoagulation therapy contin-
ued. The last intake of apixaban was 3 hours before PM lead
screwing. It was planned that a ventricular lead (Revo MRI
pacing system 5076-52; Medtronic, Minneapolis, MN,) would
be screwed into the right ventricular septal wall via the left
subclavian vein, and the position of the lead attachment was
conﬁrmed by x-ray ﬂuoroscopy. However, the lead was
unintentionally screwed toward the right ventricular free wall,
which was revealed by computed tomography after the event.
The PM generator (Advisa SRMRI A3SR01; Medtronic) was
subcutaneously ﬁxed to the left chest wall. The patient’s blood
pressure fell dramatically 3 hours following the procedure, and
ultrasonography revealed pericardial effusion.
A 6 F pericardial drainage tube (Pericardiocentesis Kit
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).inserted, and 250 mL of blood was drained. The patient’s
blood pressure and heart rate stabilized, but computed
tomography showed ventricular lead perforation (Figure 1).
The blood could not ﬂow normally, suggesting that the
drainage tube was occluded. The patient’s blood pressure
gradually decreased again. A second 6 F drainage tube was
inserted into the pericardium, and 500 mL of blood was
drained from the second drainage tube. A liquid form of
ﬁbrin glue (BOLHEAL; Kaketsuken, Japan), containing 480
mg ﬁbrinogen, 450 units of factor VIII, 6000 KIE of
aprotinin, 150 units of thrombin, and 35.4 mg calcium
chloride, was injected through the second pericardium tube
under angiographic guidance, and the patient’s blood pres-
sure stabilized immediately. Fresh frozen plasma (FFP)
(1440 mL) was administered intravenously 40 minutes after
ﬁbrin glue injection. The volume of the bloody drainage
diminished immediately and was completely resolved after
26 hours. Ultrasonography with color Doppler revealed a
dome-like structure at the right ventricular
apex, where there was a PM lead. The intra-dome space
was ﬁlled with high echoic substances, in which a small
cavity without blood ﬂow was observed on postopera-
tive day 29 (Figure 2). The ventricular lead function
was available and was within normal limits (lead impe-
dance, 494 ohm; threshold, 1.25 V/0.4 ms; and R wave,
7.3 mm).
Prior to writing this report, we explained the academic
worth of publishing this case to the patient. It was difﬁcult
for her to sign her name, so documented informed consent
was obtained from her family.Discussion
There were 2 important discoveries in this case. The ﬁrst is
that ﬁbrin glue, which is available for pericardial injection,2
can be used to stop bleeding from a lead perforation hole.
A previous report described the transpericardial use of
cyanoacrylate glue through an 8 F Judkins right guiding
catheter via a 12 F introducer sheath for pacemaker lead
perforation.3 In that report, manipulation was required for thepen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.11.001
Figure 1 Computed tomography showing ventricular lead perforation.
The black arrows illustrate the perforation of the right ventricle by the lead of
the pacemaker.
KEY TEACHING POINTS
 Fibrin glue (BOLHEAL; Kaketsuken, Japan) is
available for pericardial injection and can be used
to stop bleeding from a lead perforation hole.
 If a lead perforation is not sufﬁciently large to
facilitate bidirectional ﬂow, it is likely that the
resultant unidirectional ﬂow could lead to an
increase in the intra-dome pressure and,
consequently, to dome rupture.
 With massive hemorrhage, fresh frozen plasma may
function as a hemostat in patients taking apixaban.
81Yamaguchi et al Fibrin Glue Patch for Right Ventricular PerforationJudkins right tip to engage the perforation site. Our method
required only a 6 F pericardial catheter and did not require
positioning the tip of the catheter.
The second discovery is related to the dome-like structure,
which we assumed was a pseudoaneurysm. There was no
blood ﬂowing through this dome-like structure; instead, the
intra-dome space was ﬁlled with a high echoic mass that was
considered to represent thrombosis formation. Color Doppler
showed that the lead perforation hole was large enough to
facilitate bidirectional ﬂow (Figure 3). Hence, it is likely that
the dome had ﬁlled gradually. If the hole had been smaller, it
is likely that the ﬂow would have only been unidirectional;
this could have led to an increase in the intra-dome pressure
and, consequently, to dome rupture.
It is likely that apixaban was associated with bleeding from
the perforation site.3–5 While prothrombin complex concen-
trates work to reverse Factor Xa inhibition caused by drugs
like apixaban and may therefore be effective in such
situations, it is possible that the FFP had sufﬁcient coagulation
factors to stop the bleeding caused by Factor Xa inhibition in
this case.6 However, this is only hypothetical, as there is no
available report addressing FFP clinical use in such cases.
Thus, it is possible that it was not only the ﬁbrin glue that
acted as a hemostat, but that the FFP did as well.
As noted, there has been no report of FFP supplying Factor
Xa inhibited by apixaban,7 but the FFP had a hemostatic effect
clinically. It may be that the apixaban concentration decreased
because of its own metabolism, the bleeding, and/or infusion.
It is uncertain whether cardiac tamponade can be prevented
completely. Previous studies supported the use of passive
ﬁxation leads and uninterrupted use of warfarin rather than
heparin bridging.1,8 However, in such cases, it might be better
to discontinue apixaban rather than to continue it.
Figure 2 Postoperative ultrasonography images. A dome-shaped structure appeared on the right ventricular free wall. The coating became increasingly thick
beginning on postoperative day 7. On postoperative day 29, the inside of the dome was ﬁlled with high echoic substances, in which there was a small cavity
without blood ﬂow.
Figure 3 Color Doppler imaging. The white arrow illustrates the perforation. Blood ﬂow was moving through the hole.
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The present case suggests that ﬁbrin glue injected via a 6 F
pericardial tube into the pericardium could patch a PM lead
perforation.Acknowledgments
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